drugset / Trial / NCT00320814
Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To assess the ocular and systemic safety and tolerability of a single intravitreal injection of VEGF Trap in patients with diabetic macular edema.
Timeline
- Start
- 2006-04
- Primary completion
- 2006-08
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aflibercept | Protein / enzyme biologic | 4 mg | Intravitreal |